Your browser doesn't support javascript.
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona.
Zanelli, S; Fiorio, E; Zampiva, I; Zacchi, F; Borghesani, G; Giontella, E; Parolin, V; Biondani, P; Zuliani, S; Dieci, M V; Mioranza, E; Zorzi, M; Conti, M; Gibellini, D; Verlato, G; Milella, M.
  • Zanelli S; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Fiorio E; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Zampiva I; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy; Centro Ricerche Cliniche di Verona (CRC), Verona, Italy.
  • Zacchi F; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Borghesani G; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Giontella E; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Parolin V; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Biondani P; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Zuliani S; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.
  • Dieci MV; Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy; Department of Oncology, Surgery and Gastroenterology, University of Padova, Padua, Italy.
  • Mioranza E; Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
  • Zorzi M; Veneto Tumor Registry, Azienda Zero, Padua, Italy.
  • Conti M; Section of Infectious Diseases, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Gibellini D; Department of Diagnostic and Public Health, Microbiology Section, University of Verona, Verona, Italy.
  • Verlato G; Section of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Milella M; Section of Oncology, Department of Medicine, University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy. Electronic address: michele.milella@univr.it.
Ann Oncol ; 33(6): 661-663, 2022 06.
Article in English | MEDLINE | ID: covidwho-1729527

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.annonc.2022.02.227

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2022 Document Type: Article Affiliation country: J.annonc.2022.02.227